CEFTRIAXONE
Antibiotic
Strength1000 mg
Forminjection
1-2 g once daily by intravenous or intramuscular injection - Reviewed at 48 hours - failure to improve by then is an indication for mastoidectomy
50-75 mg/kg/dose [child max 1000 mg]
(Infants, children and adolescents, mild to moderate infection: 50-75 mg/kg as a single daily dose, maximum 1,000 mg a day. Severe infection: 100 mg/kg/day divided every 12 to 24 hours, maximum 4,000 mg/day.)
| 3kg | 150-225 mg/dose |
|---|---|
| 4kg | 200-300 mg/dose |
| 5kg | 250-375 mg/dose |
| 6kg | 300-450 mg/dose |
| 7kg | 350-525 mg/dose |
| 8kg | 400-600 mg/dose |
| 9kg | 450-675 mg/dose |
| 10kg | 500-750 mg/dose |
| 11kg | 550-825 mg/dose |
| 12kg | 600-900 mg/dose |
| 13kg | 650-975 mg/dose |
| 14kg | 700-1000 mg/dose (upper capped) |
| 15kg | 750-1000 mg/dose (upper capped) |
| 16kg | 800-1000 mg/dose (upper capped) |
| 17kg | 850-1000 mg/dose (upper capped) |
| 18kg | 900-1000 mg/dose (upper capped) |
| 19kg | 950-1000 mg/dose (upper capped) |
| 20kg | 1000 mg/dose (capped) |
| 21kg | 1000 mg/dose (capped) |
| 22kg | 1000 mg/dose (capped) |
| 23kg | 1000 mg/dose (capped) |
| 24kg | 1000 mg/dose (capped) |
| 25kg | 1000 mg/dose (capped) |
| 26kg | 1000 mg/dose (capped) |
| 27kg | 1000 mg/dose (capped) |
| 28kg | 1000 mg/dose (capped) |
| 29kg | 1000 mg/dose (capped) |
| 30kg | 1000 mg/dose (capped) |
| 31kg | 1000 mg/dose (capped) |
| 32kg | 1000 mg/dose (capped) |
| 33kg | 1000 mg/dose (capped) |
| 34kg | 1000 mg/dose (capped) |
| 35kg | 1000 mg/dose (capped) |
| 36kg | 1000 mg/dose (capped) |
| 37kg | 1000 mg/dose (capped) |
| 38kg | 1000 mg/dose (capped) |
| 39kg | 1000 mg/dose (capped) |
| 40kg | 1000 mg/dose (capped) |
| 41kg | 1000 mg/dose (capped) |
| 42kg | 1000 mg/dose (capped) |
| 43kg | 1000 mg/dose (capped) |
| 44kg | 1000 mg/dose (capped) |
| 45kg | 1000 mg/dose (capped) |
| 46kg | 1000 mg/dose (capped) |
| 47kg | 1000 mg/dose (capped) |
| 48kg | 1000 mg/dose (capped) |
| 49kg | 1000 mg/dose (capped) |
| 50kg | 1000 mg/dose (capped) |
WATCH group - carries resistance cost. Egyptian EML 2025.
Egyptian National Drug Formulary - Antimicrobial 2023 (ceftriaxone monograph, p255)
The cited article says antibiotics are the centrepiece of treatment, that most patients with acute mastoiditis are admitted, and that the uncomplicated patient with no significant history has been treated successfully as an outpatient on daily intravenous ceftriaxone with a low complication rate. The formulary's ceftriaxone monograph names acute otitis media - the infection mastoiditis grows out of - among its indications and gives the paediatric weight rule below. Antibiotics alone still leave an 8.5% complication rate in the article's figures, which is why this drug goes with a referral and not instead of one.
- SEND THE PATIENT IN. The article says most patients with acute mastoiditis are admitted, and that a myringotomy with a grommet, or a mastoidectomy, may be needed alongside the antibiotic.
- REVIEW AT 48 HOURS. The article says mastoidectomy is indicated if mastoiditis has not improved by then, and warns that the clinical state can deteriorate quickly - serial examination, not one look.
- WHAT MAKES IT COMPLICATED, in the article's words: a large lesion behind the ear, bone erosion on imaging, high fever, or any neurological sign. Any of these and outpatient treatment is off the table.
- The article's own first choice for the inpatient without chronic otitis media is intravenous vancomycin alone, with an anti-pseudomonal drug added where there is a long history of ear infection. Neither the article nor the Egyptian formulary states a vancomycin dose, so no vancomycin row is printed here - that dose has to come from the admitting unit.
- Do not give to anyone with a known allergy to ceftriaxone or another cephalosporin. Never with an intravenous calcium-containing fluid in a baby of 28 days or under, and not in a jaundiced newborn.
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| ZOXIDEL 1 GM PD. FOR I.M. INJ. | RAMEDA > DELTA PHARMA | 22.00 EGP |
| CEFTRIAXONE SODIUM 1 GM I.M.VIAL (KAHIRA) | KAHIRA | 29.00 EGP |
| ZOXIDEL 1 GM PD. FOR I.V. INJ. | RAMEDA > DELTA PHARMA | 29.00 EGP |
| WINTRIAXONE 1 GM PD. FOR I.V INJ. | SANOFI | 48.00 EGP |
| VOTRIAXONE 1 GM I.M VIAL | CHEMIPHARM | 56.00 EGP |
| OFRAMAX 1 GM I.M. VIAL | RAMEDA > SUN PHARMA EGYPT LIMITED | 71.00 EGP |
| TRIAXONE 1 GM I.M. VIAL | TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA | 106.00 EGP |
| TRIAXONE 1 GM I.V VIAL | TABUK PHARMACEUTICAL MANUFACTURING COMPANY > TABUK PHARMA | 106.00 EGP |